EVERSANA expanded its AI-powered commercialization platform, adding medical affairs and commercial capabilities. The update includes agentic AI orchestration plus workflow automation for content development, medical information support, market research, MLR automation, and analytics. For service-model partners and biopharma internal teams, the message is that AI deployment is moving from pilots toward integrated operating workflows—while staying tied to governance and compliance requirements.